KING STREET CAPITAL MANAGEMENT, L.P.KING STREET CAPITAL MANAGEMENT, L.P.

Institutional investor · Portfolio as of Q2 2024

Top Holdings8 positions

Checking export access…
Activity:

AVEANNA HEALTHCARE HLDGS INC COM

6.4M$17.7M22.2%$1.67+65.05%
7 qtrssince 2022-Q4
Unchanged
0
19.8M$15.6M19.6%——
5 qtrssince 2023-Q2
Increased
73

ARDAGH METAL PACKAGING S A SHS

4.4M$14.8M18.6%$2.940.00%
1 qtr
New
90
16.5M$13.3M16.7%——
1 qtr
New
89
11.5M$7.2M9.0%——
8 qtrssince 2022-Q3
Unchanged
0
6.7M$5.9M7.4%——
9 qtrssince 2022-Q2
Unchanged
0

ALTICE USA INC

2.5M$5.1M6.4%$2.040.00%
1 qtr
New
86
333,333$23,3330.0%——
5 qtrssince 2023-Q2
Unchanged
0
$79.5M
AUM
8
Positions
Q2 2024
Filing
HI score · 1.5/5
Quarterly 13F Value Change
-2%Q2'21$1.2B-3%Q3'21$1.2B-2%Q4'21$1.2B-8%Q1'22$1.1B-37%Q2'22$674.3M-23%Q3'22$522.1M
Activity profile
$ moved · Q2'24
New10%Increased1%Decreased0%Exited89%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.7 years
<1Q25%1-4Q0%1-2Y38%2Y+38%

KING STREET CAPITAL MANAGEMENT, L.P. manages $79.5M across 8 positions as of Q2 2024. Top holdings: AVAH (22.2%), UPSTART HLDGS INC (19.6%), AMBP (18.6%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.

Q2 2024 Summary

Added 3 new positions, exited 2, increased 1. Top move: AMBP (NEW, conviction 90). Portfolio: $80M across 8 positions.

Top holdings by portfolio weight

Total AUM$80M
AVAH22.21%
UPSTART HLDG19.63%
AMBP18.60%
ANYWHERE REA16.70%
DISH NETWORK9.00%
BRAEMAR HOTE7.42%
OPTU6.41%
ALPHA PARTNE0.03%
VMRK0.00%
AVB0.00%

Portfolio allocation by GICS sector

Sectors3
Healthcare47.04%
Consumer Cyclical39.38%
Communication Services13.58%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L33
Conviction48
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used